New drug for Alzheimer’s illness coated by insurance coverage for about 2.98 million yen per yr Chuikyo | NHK

The Chuikyo (Central Social Insurance Medical Council) has determined to set the value of “recanemab,” a brand new drug that immediately targets the causative agent of Alzheimer’s illness, at roughly 2.98 million yen per affected person per yr, making it eligible for insurance coverage protection. .

Source